Help First Generation Law Students
Succeed Through Education
Dear friend,
As you may already know, Yunhui passed away in June after battling an aggressive form of cancer called Leiomyosarcoma. She was only 61 years old and three months into enjoying a well-earned retirement when she received her diagnosis. The shock of her loss remains as profound today as it was on the day she left us. In her honor, Yunhui's family and friends have created a scholarship in her name at New York Law School.
Yunhui wanted to help immigrants and first-generation students overcome barriers to higher education. She passed away less than a year after retiring. So she never had a chance to pursue her ideas of helping others succeed to the extent she wanted to. We established this scholarship in memory of Yunhui - her legacy will live on by helping others achieve their dreams of a higher education.
Yunhui's life story is a testament to her ideals of perseverance and education. When she was just two years old, her father passed away, leaving her mother to provide for the family. At the age of 12, Yunhui immigrated from South Korea to the United States with her mother, Yim, and sister, Song. Despite the challenges of being a new immigrant, she taught herself English and began her pursuit of the American dream. Yunhui and her sister became the first in their family to graduate from high school. They both earned bachelor's degrees. Then Yunhui went on to receive her JD from New York Law School. Her personal journey taught her the power of education, and she wanted to help others access these same opportunities.
We have set an ambitious goal of raising $250,000 to establish a lasting scholarship in Yunhui's name. This fund will ensure that her legacy continues to inspire and support future generations for years to come. We're off to a strong start and need your help to make it a reality. Your contribution, no matter the size, will make a significant impact. Please click the "Donate" button below to visit the New York Law School scholarship donation page for Yunhui and make your gift today.
Double Your Impact with a Matching Gift
You can double your impact with a corporate matching gift. It's easy: Ask your employer if they have a matching gift program, fill out your employer's matching gift form, and return it. We'll take care of the rest.
Gifting Stock
If you wish to donate stock, complete the Stock Transfer Form, then send the form to your investment advisor and NY Law School Alumni at alumni@nyls.edu. We use the information to track and acknowledge your gift.
Tax Deductible Donation
Donations to the Yunhui Chae-Banks First Generation Scholarship Fund are tax-deductible. The New York Law School Alumni Fund is a 501(c)(3) organization.
Get in Touch
My family and friends have set up a scholarship fund at New York Law School to honor me and my life. Aren't they sweet?
They would also like to hear from you. Yes, really! I made friends around the world, and having died only a few months after retiring, I didn't have a chance to connect with everyone I knew. My family is still here. I miss them, and they miss me. Drop them a note; they would love to hear from you. It's one way to remember me in a loving way.
YCB
What is Leiomyosarcoma?
Sarcoma
Sarcomas are rare cancers that develop in the bones and soft tissues, including fat, muscles, blood vessels, nerves, deep skin tissues and fibrous tissues. According to the National Cancer Institute, about 12,000 cases of soft tissue sarcomas and 3,000 cases of bone sarcomas are diagnosed in the U.S. each year.
Leiomyosarcoma
Leiomyosarcoma, or LMS, is a type of rare cancer that grows in the smooth muscles. The smooth muscles are in the hollow organs of the body, including the intestines, stomach, bladder, and blood vessels. In females, there is also smooth muscle in the uterus.
How do you
get LMS?
We don't have an answer for this question. We do know that it is often misdiagnosed or dismissed. If your doctor can't diagnose a problem, don't wait - go get a second or third opinion.
Clinical
Research
Clinical trials for treating sarcomas are available. These trials are typically retesting chemo and immuno-therapies that have had success treating other cancers, which often don't work on sarcomas. The most promising trials and therapies are taking place outside the major pharmaceutical companies and therefore lack sufficient funds to make significant progress.